BREAKING NEWS
OK LogoNEWS

Paula Deen Donating a "Certain Percentage" of Diabetes Drug Endorsement Deal to ADA

Paula deen diabtes jan19nea.jpg

Jan. 19 2012, Published 4:50 a.m. ET

Link to FacebookShare to TwitterShare to Email

Paula Deen may be the new face of the diabetes drug company Nova Nordisk, but she's defending that decision by saying a portion of the profits will be donated to the American Diabetes Association.

OK! NEWS: PAULA DEEN HAS TYPE 2 DIABETES — "IT'S NOT A DEATH SENTENCE"

After announcing she has Type 2 Diabetes this week, Paula appeared on ABC's The Chew on Wednesday and discussed her diagnosis.

The Food Network star said she was diagnosed three years ago, but didn't want to share that because she felt she didn't have "anything to bring to the table."

Article continues below advertisement

After learning about diabetes and coping with her diagnosis, Paula feels she can talk openly about it.

"I've always said moderation. I don't eat every day like you see me cook on that show," Paula said, defended her recipes. "It's 30 days of my life, and it's for your entertainment."

"I don't blame myself for my Type 2 Diabetes," she said.

OK! NEWS: ANTHONY BOURDAIN ON PAULA DEEN'S DIABETES DRUG ENDORESMENT — "IT'S IN BAD TASTE"

She now takes Victoza and is working with the drug company for a New Light campaign.

Paula said she and her two sons, Bobby and Jamie, are working with them "because we, like everybody else, have to work."

However, she said they are "in a position" to "set aside a certain percentage and we're donating that back to the ADA."

Are you glad to hear Paula is donating to the ADA?

Advertisement

Want OK! each day? Sign up here!

© Copyright 2022 OK!. A DIVISION OF EMPIRE MEDIA GROUP HOLDINGS LLC. OK! is a registered trademark. All rights reserved. Registration on or use of this site constitutes acceptance of our Terms of Service, Privacy Policy and Cookies Policy. People may receive compensation for some links to products and services. Offers may be subject to change without notice.